◀ Back to EDN3
AVP — EDN3
Pathways - manually collected, often from reviews:
Text-mined interactions from Literome
Yamamoto et al., Neurosci Lett 1992
:
No difference of the
effects of ET-1 and
ET-3 on
AVP release was observed
Postma et al., Neth J Med 2005
:
The
effect of
arginine vasopressin on
endothelin production in the human forearm vascular bed ... To study whether
arginine vasopressin (AVP) can
stimulate endothelin production and/or release in vivo, in the human forearm vasculature ... In another group the
effects of
AVP on
endothelin production were studied after a prior infusion of L-NG-monomethyl-arginine ( L-NMMA ), a nitric oxide-synthase inhibitor
Tomita et al., J Clin Invest 1990
:
The
effects of
endothelin on
arginine vasopressin (AVP)- , parathyroid hormone-, glucagon-, calcitonin-, and isoproterenol dependent cAMP accumulation were studied
Rossi et al., Am J Physiol 1995
:
The present studies were designed to ascertain the site of action and the participation of membrane cation channels mediating
endothelin-3 induced
AVP release
Rossi et al., J Physiol 1993
:
We used cultured explants of the hypothalamo-neurohypophysial complex ( HNC ) to examine the
effects of
ET-3 on
AVP release ...
ET-3 ( 1 nM )
induced a 3-fold rise in
AVP that was completely blocked by rabbit antiET serum, which did not alter basal AVP secretion
Kohno et al., Am J Physiol 1993
:
Natriuretic peptides inhibit mesangial cell production of
endothelin induced by
arginine vasopressin
Kim et al., Mol Cell Endocrinol 1996
(Carcinoma, Small Cell) :
0.1 microM
endothelin 3 (ET3) , 1 microM angiotensin II ( AII ), and 10 microM acetylcholine (Ach) significantly
increased AVP release ; ET3 ( C 1.78 +/- 0.20 vs. ET3 6.85 +/- 1.86 pg/2 x 10 ( 6 ) cells, N = 8, P < 0.02 ) ; AII ( C 1.29 +/- 0.38 vs. AII 27.80 +/- 7.09 pg/2 x 10 ( 6 ) cells, N = 5, P < 0.05 ) and Ach ( C 1.14 +/- 0.33 vs. Ach 2.68 +/- 0.58 pg/2 x x10 ( 6 ) cells, N = 6, P < 0.05 ) ... To localize the region of the
AVP promoter that
mediates the osmotic stimulation and the effect of
ET3 , 5 ' deletions of the AVP promoter fragments terminating at -532, -211, and -102, was assessed